These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 33771405)
41. Health-related quality-of-life results for pembrolizumab versus chemotherapy in advanced, PD-L1-positive NSCLC (KEYNOTE-024): a multicentre, international, randomised, open-label phase 3 trial. Brahmer JR; Rodríguez-Abreu D; Robinson AG; Hui R; Csőszi T; Fülöp A; Gottfried M; Peled N; Tafreshi A; Cuffe S; O'Brien M; Rao S; Hotta K; Zhang J; Lubiniecki GM; Deitz AC; Rangwala R; Reck M Lancet Oncol; 2017 Dec; 18(12):1600-1609. PubMed ID: 29129441 [TBL] [Abstract][Full Text] [Related]
42. Health-Related Quality of Life in KEYNOTE-010: a Phase II/III Study of Pembrolizumab Versus Docetaxel in Patients With Previously Treated Advanced, Programmed Death Ligand 1-Expressing NSCLC. Barlesi F; Garon EB; Kim DW; Felip E; Han JY; Kim JH; Ahn MJ; Fidler MJ; Gubens MA; de Castro G; Surmont V; Li Q; Deitz AC; Lubiniecki GM; Herbst RS J Thorac Oncol; 2019 May; 14(5):793-801. PubMed ID: 30711649 [TBL] [Abstract][Full Text] [Related]
43. Integrative oncology for patients with lung cancer: A prospective pragmatic controlled trial. Ben-Arye E; Gressel O; Lifshitz S; Peled N; Keren S; Samuels N Lung Cancer; 2024 Jul; 193():107857. PubMed ID: 38941654 [TBL] [Abstract][Full Text] [Related]
44. Relationships of Symptom Groups and Functioning Domains in Patients with Advanced-Stage Non-Small Cell Lung Cancer Undergoing Treatment: A Cross-Sectional Study. Lee MK Healthcare (Basel); 2020 Dec; 9(1):. PubMed ID: 33396797 [TBL] [Abstract][Full Text] [Related]
45. Quality-of-life outcomes for adjuvant chemotherapy in early-stage non-small-cell lung cancer: results from a randomized trial, JBR.10. Bezjak A; Lee CW; Ding K; Brundage M; Winton T; Graham B; Whitehead M; Johnson DH; Livingston RB; Seymour L; Shepherd FA J Clin Oncol; 2008 Nov; 26(31):5052-9. PubMed ID: 18809617 [TBL] [Abstract][Full Text] [Related]
46. Assessment of quality of life (QoL) in breast cancer patients by using EORTC QLQ-C30 and BR-23 questionnaires: A tertiary care center survey in the western region of Saudi Arabia. Imran M; Al-Wassia R; Alkhayyat SS; Baig M; Al-Saati BA PLoS One; 2019; 14(7):e0219093. PubMed ID: 31291302 [TBL] [Abstract][Full Text] [Related]
47. Prospective external convergence evaluation of two different quality-of-life instruments in lung resection patients. Pompili C; Brunelli A; Xiumé F; Refai M; Salati M; Socci L; Di Nunzio L; Sabbatini A Eur J Cardiothorac Surg; 2011 Jul; 40(1):99-105. PubMed ID: 21159520 [TBL] [Abstract][Full Text] [Related]
48. [Impact of erlotinib treatment on symptoms and quality of life in patients with advanced non-small-cell lung cancer]. Zhou SW; Ren SX; Yan LH; Zhang L; Zhou CC Zhonghua Zhong Liu Za Zhi; 2008 Jun; 30(6):469-72. PubMed ID: 19024526 [TBL] [Abstract][Full Text] [Related]
49. Effects of systematic rehabilitation programs on quality of life in patients undergoing lung resection. Li XH; Zhu JL; Hong C; Zeng L; Deng LM; Jin LY Mol Clin Oncol; 2013 Jan; 1(1):200-208. PubMed ID: 24649148 [TBL] [Abstract][Full Text] [Related]
50. Treatment Satisfaction of Patients With Advanced Non-Small-cell Lung Cancer Receiving Platinum-based Chemotherapy: Results From a Prospective Cohort Study (PERSONAL). Visser S; de Mol M; Cheung K; van Toor JJ; van Walree NC; Stricker BH; Den Oudsten BL; Aerts JGJV Clin Lung Cancer; 2018 Jul; 19(4):e503-e516. PubMed ID: 29705017 [TBL] [Abstract][Full Text] [Related]
51. Comparing Health-Related Quality of Life among Breast Cancer Patients Receiving Different Plans of Treatment, Egypt. Mortada EM; Salem RA; Elseifi OS; Khalil OM J Community Health; 2018 Dec; 43(6):1183-1191. PubMed ID: 29876788 [TBL] [Abstract][Full Text] [Related]
52. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. Aaronson NK; Ahmedzai S; Bergman B; Bullinger M; Cull A; Duez NJ; Filiberti A; Flechtner H; Fleishman SB; de Haes JC J Natl Cancer Inst; 1993 Mar; 85(5):365-76. PubMed ID: 8433390 [TBL] [Abstract][Full Text] [Related]
53. Quality of life after the initial treatments of non-small cell lung cancer: a persistent predictor for patients' survival. Lemonnier I; Guillemin F; Arveux P; Clément-Duchêne C; Velten M; Woronoff-Lemsi MC; Jolly D; Baumann C Health Qual Life Outcomes; 2014 May; 12():73. PubMed ID: 24884836 [TBL] [Abstract][Full Text] [Related]
54. Survival as a clinical outcome and its spiritual significance in a cohort of patients with advanced central pelvic neoplastic disease undergoing total pelvic evisceration: a poorly debated issue. Macciò A; Sanna E; Piras R; Lavra F; Vallerino V; Maricosu G; Giglio E; Mura A; Tidore M; Madeddu C Front Med (Lausanne); 2023; 10():1173687. PubMed ID: 37359011 [TBL] [Abstract][Full Text] [Related]
55. Quality of Life in Patients with Advanced Non-Small-Cell Lung Cancer Receiving Palliative Chemotherapy. Daroszewski C; Stasiewicz M; Jaźwińska-Tarnawska E; Rachwalik A; Mura E; Luboch-Kowal J; Dryś A; Bogucki ZA; Brzecka A Adv Exp Med Biol; 2019; 1160():11-18. PubMed ID: 30825114 [TBL] [Abstract][Full Text] [Related]
56. [A study on quality of life after thoracoscopic assistant lobectomy for lung cancer]. Zeng J; Liu J Zhongguo Fei Ai Za Zhi; 2014 Mar; 17(3):209-14. PubMed ID: 24667257 [TBL] [Abstract][Full Text] [Related]
57. Concurrent chemoradiotherapy degrades the quality of life of patients with stage II nasopharyngeal carcinoma as compared to radiotherapy. Pan XB; Huang ST; Chen KH; Jiang YM; Ma JL; Qu S; Li L; Chen L; Zhu XD Oncotarget; 2017 Feb; 8(8):14029-14038. PubMed ID: 28152511 [TBL] [Abstract][Full Text] [Related]
58. Assessment of health-related quality of life in end-stage chronic obstructive pulmonary disease and non-small-cell lung cancer patients in Serbia. Maric D; Jovanovic D; Nagorni-Obradovic L; Stjepanovic M; Kisic-Tepavcevic D; Pekmezovic T Palliat Support Care; 2016 Feb; 14(1):60-8. PubMed ID: 26033400 [TBL] [Abstract][Full Text] [Related]
59. Quality of life assessment of second-line docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy: results of a prospective, randomized phase III trial. Dancey J; Shepherd FA; Gralla RJ; Kim YS Lung Cancer; 2004 Feb; 43(2):183-94. PubMed ID: 14739039 [TBL] [Abstract][Full Text] [Related]
60. Quality of life-related outcomes from a patient-tailored integrative medicine program: experience of Russian-speaking patients with cancer in Israel. Sharabi IS; Levin A; Schiff E; Samuels N; Agour O; Tapiro Y; Lev E; Keinan-Boker L; Ben-Arye E Support Care Cancer; 2016 Oct; 24(10):4345-55. PubMed ID: 27169571 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]